When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?

Psychiatric Quarterly

Volumn 70, Issue 4, 1999, Pages 333-346

  Thase, Michael E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

BODY WEIGHT DISORDER; CONFERENCE PAPER; DEPRESSION; HUMAN; INSOMNIA; PSYCHOTHERAPY; RELAPSE; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; TREATMENT INDICATION;

EID: 0032745709     PISSN: 00332720     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1022042316895     Document Type: Conference Paper

References (47)

1. American Psychiatric Association: Practice guideline for major depressive disorder in adults. American Journal of Psychiatry 150:1-26, 1993.
2. Persons JB, Thase ME, Crits-Christoph P: The role of psychotherapy in the treatment of depression. Archives of General Psychiatry 53:283-290, 1996.
3. Depression Guideline Panel: Clinical practice guideline number 5. Depression in primary care, vol. 2. Treatment of major depression (AHCPR Publication No. 93-0551). Rockville, U.S. Department of Health and Human Services Agency for Health Care Policy and Research, 1993.
4. Thase ME: Psychopharmacology in conjunction with psychotherapy, in Handbook of Psychological Change: Psychotherapy Processes and Practices for the 21st Century. Edited by Ingram R, Snyder RC. New York, John Wiley & Sons, in press.
5. Thase ME: The role of axis II comorbidity in the management of patients with treatment resistant depression. Psychiatric Clinics of North America 19(2):287-309, 1996.
6. Joyce PR, Paykel ES: Predictors of drug response in depression. Archives of General Psychiatry 46:89-99, 1989.
7. Thase ME, Howland R: Refractory depression: relevance of psychosocial factors and therapies. Psychiatric Annals 24:232-240, 1994.
8. Thase ME, Greenhouse JB, Frank E, et al: Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Archives of General Psychiatry 54:1009-1015, 1997.
9. Simons AD, Gordon JS, Monroe SM, et al: Toward an integration of psychologic, social, and biologic factors in depression: effects on course and outcome of cognitive therapy. Journal of Consulting and Clinical Psychology 63:369-377, 1995.
10. Thase ME, Friedman ES: Is psychotherapy, alone, an effective treatment for melancholia and other severe depressive states? Journal of Affective Disorders (in press).
11. Elkin I, Shea MT, Watkins JT, et al: National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness and treatments. Archives of General Psychiatry 46:971-982, 1989.
12. Thase ME, Simons AD, Cahalane J, et al: Severity of depression and response to cognitive behavior therapy. American Journal of Psychiatry 148:784-789, 1991.
13. Hollon SD, DeRubeis RJ, Evans MD, et al: Cognitive therapy and pharmacotherapy for depression singly and in combination. Archives of General Psychiatry 49:774-781, 1992.
14. Klein DF, Ross DC: Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program general effectiveness report. Neuropsychopharmacology 8:241-251, 1993.
15. Elkin I, Gibbons RD, Shea MT, et al: Initial severity and differential treatment outcome in the National Institue of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology 63:841-847, 1995.
16. Stewart JW, Garfinkel R, Nunes EV, et al: Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Clinical Psychopharmacology 18:429-434, 1998.
17. Thase ME, Buysse DJ, Frank E, et al: Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal electroencephalographic sleep profiles. American Journal of Psychiatry 154:502-509, 1997.
18. Sotsky SM, Glass DR, Shea MT : Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry 148:997-1008, 1991.
19. Riso L, Thase ME, Howland RH, et al: A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy. Journal of Affective Disorders 43:131-142, 1997.
20. Kendall PC, Kipnis D, Otto-Salaj L: When clients don't progress: Influences on and explanations for lack of therapeutic progress. Cognitive Therapy Research 16:269-281, 1992.
21. Buysse DJ, Tu XM, Cherry CR, et al: Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biological Psychiatry 45:205-213, 1999.
22. Thase ME, Simons AD, Reynolds CF III: Abnormal electroencephalographic sleep profiles in major depression. Association with response to cognitive behavior therapy. Archives of General Psychiatry 53:99-108, 1996.
23. Thase ME, Dubé S, Bowler K, et al: Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. American Journal of Psychiatry 153:886-891, 1996.
24. Thase ME, Reynolds CF III, Frank E, et al: Polysomnographic studies of unmedicated depressed men before and after treatment with cognitive behavior therapy. American Journal of Psychiatry 151:1615-1622, 1994.
25. Thase ME, Fasiczka AL, Berman SR, et al: Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Archives of General Psychiatry 55:138-144, 1998.
26. Frank E, Kupfer DJ, Perel JM, et al: Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 47:1093-1099, 1990.
27. Kocsis JH, Friedman RA, Markowitz JC, et al: Maintenance therapy for chronic depression - a controlled clinical trial of desipramine. Archives of General Psychiatry 53:769-776, 1996.
28. Reynolds CF III, Frank E, Perel JM, et al: Nortriptyline and interpersonal psychotherapy as maintenance therpaies for recurrent major depression. A randomized controlled trial in patients older than 59 years. Journal of the American Medical Association 182:39-45, 1999.
29. Evans MD, Hollon SD, DeRubeis RJ, et al: Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 49:802-808, 1992.
30. Blackburn IM, Moore RG: Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. British Journal of Psychiatry 171:328-334, 1997.
31. Spanier C, Frank E, McEachran AB, et al: The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors. Psychological Medicine 26:461-475, 1996.
32. Fava G, Grandi S, Zielezny M, et al: Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. American Journal of Psychiatry 151:1295-1299, 1994.
33. Fava GA, Grandi S, Zielezny M, et al: Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry 153:945-947, 1996.
34. Fava GA, Rafanelli C, Grandi S, et al: Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry 155:1443-1445, 1998.
35. Dashevsky BA, Kramer M: Behavioral treatment of chronic insomnia in psychiatrically ill patients. Journal of Clinical Psychiatry 59:693-699, 1998.
36. Cochran SD: Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology 52:873-878, 1984.
37. Bowers WA: Treatment of depressed in-patients Cognitive therapy plus medication, relaxation plus medication, and medication alone. British Journal of Psychiatry 156:73-78, 1990.
38. Miller IW, Norman WH, Keitner GI: Cognitive-behavioral treatment of depressed inpatients: six- and twelve-month follow-up. American Journal of Psychiatry 146:1274-1279, 1989.
39. Clarkin JF, Glick ID, Haas GL, et al: A randomized clinical trial of inpatient family intervention. V. Results for affective disorders. Journal of Affective Disorders 18:17-28, 1990.
40. Miller IW, Norman WH, Keitner GI: Treatment response of high cognitive dysfunction depressed inpatients. Comprehensive Psychiatry 30:62-71, 1990.
41. Thase ME, Rush AJ, Kaspar S, Nemeroff C: Tricyclics and newer antidepressant medications: treatment options for treatment resistant depressions. Depression 152:152-168, 1995.
42. Fava GA, Savron G, Grandi S, et al: Cognitive-behavioral management of drug-resistant major depressive disorder. Journal of Clinical Psychiatry 58:278-282, 1997.
43. Goldman W, McCulloch J, Cuffel B, et al: Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatric Services 49:477-482, 1998.
44. Dewan M: Are psychiatrists cost-effective? An analysis of integreated versus split treatment. American Journal of Psychiatry 156:324-326, 1999.
45. Blackburn IM, Bishop S, Glen AIM, et al: The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Pyschiatry 139:181-189, 1981.
46. Teasdale JD, Fennell MJV, Hibbert GA, et al: Cognitive therapy for major depressive disorder in primary care. British Journal of Psychiatry 144:400-406, 1984.
47. Schulberg HC, Block MR, Madonia MJ, et al: Treating major depression in primary care practice. Eight-month clinical outcomes. Archives of General Psychiatry 53:913-919, 1996.